Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
15.14
-0.07 (-0.46%)
Nov 4, 2024, 4:00 PM EST - Market closed
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MD stock have an average target of 13.25, with a low estimate of 9.00 and a high estimate of 16. The average target predicts a decrease of -12.48% from the current stock price of 15.14.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for MD stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Maintains $9 → $15 | Hold | Maintains | $9 → $15 | -0.92% | Nov 4, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $13 → $16 | Hold | Maintains | $13 → $16 | +5.68% | Nov 4, 2024 |
| Mizuho | Mizuho | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | -0.92% | Nov 4, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $10 → $13 | Hold | Maintains | $10 → $13 | -14.13% | Oct 7, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $8 → $14 | Hold → Strong Buy | Upgrades | $8 → $14 | -7.53% | Sep 26, 2024 |
Financial Forecast
Revenue This Year
2.04B
from 1.99B
Increased by 2.42%
Revenue Next Year
2.01B
from 2.04B
Decreased by -1.71%
EPS This Year
1.31
from -0.73
EPS Next Year
1.50
from 1.31
Increased by 14.24%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.1B | 2.2B | 2.3B |
| Avg | 2.0B | 2.0B | 2.1B |
| Low | 1.9B | 1.8B | 1.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 6.5% | 7.4% | 12.2% |
| Avg | 2.4% | -1.7% | 2.6% |
| Low | -5.8% | -11.4% | -7.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.39 | 1.66 | 1.63 | |
| Avg | 1.31 | 1.50 | 1.53 | |
| Low | 1.21 | 1.25 | 1.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 26.3% | 8.4% | |
| Avg | - | 14.2% | 2.2% | |
| Low | - | -4.5% | -8.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.